Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNorthwell Health

About this trial

Gastric outlet obstruction (GOO) occurs commonly in malignancies involving the periampullary region (cancers originating in the head of the pancreas, duodenum, bile duct, or ampulla) or the distal stomach. GOO not only causes debilitating symptoms such as nausea, vomiting, inability to tolerate oral intake, and prevents adequate nutritional intake. Therefore, providing therapy for GOO is imperative to improve the quality of life, and nutritional status of these patients, as well as allow them to continue receiving their cancer treatment

Eligibility criteria

Qualifiers

Periampullary malignancy (pancreas, bile duct, ampulla, duodenum) extending to the distal duodenum (D3) or distal (antrum) gastric cancer

post prandial vomiting,

abdominal pain,

inability to tolerate PO,

Disqualifiers

Age< 18 years old

Pregnancy

Intestinal obstruction distal to the Ligament of Treitz

Evidence of other luminal strictures of the GI tract

Trial design

Treatments tested in this trial

  • Surgical gastrojejunostomy (SGJ)
  • Endoscopic gastrojejunostomy (EGJ)

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Northwell Health

Lead sponsor

Rutgers, The State University of New Jersey

Collaborator